Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1104520190190010011
Journal of Endocrine Surgery
2019 Volume.19 No. 1 p.11 ~ p.17
Impact of Minimal Extrathyroidal Extension on Recurrence in Papillary Thyroid Carcinoma Measuring 4 cm or Less without Clinical Lymph Node Metastasis
Park Jin-Woo

Lee Ok-Jun
Son Seung-Myoung
Woo Chang-Gok
Abstract
Purpose: American Thyroid Association's guidelines (2015) recommend that papillary thyroid carcinomas (PTCs) ¡Â4 cm without extrathyroidal extension (ETE) and clinical lymph node metastasis (cLNM) can be treated by a unilateral procedure if a slightly higher risk of locoregional recurrence is accepted. The aim of the present study is to evaluate impact of minimal ETE (mETE) on locoregional recurrence in PTCs ¡Â4 cm without cLNM.

Methods: The medical records of patients who underwent thyroidectomy for PTC ¡Â4 cm between January 1, 2007 and December 31, 2013 were retrospectively reviewed. Patients who had PTC with gross ETE and/or cLNM were excluded.-Patients with papillary thyroid microcarcinoma (PTMC) without ETE (group I; n=381) were compared with three other groups of patients: PTC 1?4 cm without ETE (group II; n=150); PTC ¡Â1 cm with mETE (group III; n=186); and PTC 1?4 cm with mETE (group IV; n=121). Mean follow-up period was 72.2¡¾26.4 months.

Results: Multiplicity, bilaterality, LNM, and total thyroidectomy were more common in group III and IV. Five-year disease-free survival (DFS) was 100%, 97.9%, 95.9%, and 94.9% in group I, II, III, and IV, respectively. DFS rates were significantly higher in group I compared to the other groups (P<0.01). There were no significant differences among group II, III, and IV.

Conclusion: Compared to PTMC without ETE, mETE in PTC ¡Â4 cm without cLNM may be associated with more aggressive biological behavior and increased risk of recurrence, although the increments may be relatively small.
KEYWORD
Papillary thyroid carcinoma, Extrathyroidal extension, Lymph node metastasis, Disease-free survival
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed